Biological activity of synthesized 5-{1-[(4-chlorophenyl)sulfonyl]piperidin-4- yl}-2-mercapto-1,3,4-oxadiazole derivatives demonstrated by in silico and BSA binding studies. Braz. J. Pharm. Sci. [Internet]. 2020 Dec. 9 [cited 2024 May 5];56:e18092. Available from: https://www.revistas.usp.br/bjps/article/view/182524